chloroquine has been researched along with griseofulvin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (33.33) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Kalaria, PN; Raval, DK; Satasia, SP | 1 |
| Karad, SC; Purohit, VB; Raval, DK | 1 |
| Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Doshi, H; Ray, A; Thakkar, SS; Thakor, P | 1 |
| Doshi, H; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P | 1 |
| Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD | 1 |
| Bazyka, DA | 1 |
| Bhutani, LK; Bikhchandani, R; Deshpande, SG; Kandhari, KC; Narang, BS | 1 |
| Dighe, S; Gurbarg, M; Noory, A; Shah, VP; Skelly, JP | 1 |
| Donald, GF; Hunter, GA; Roman, W; Taylor, AE | 1 |
| Doss, M | 1 |
| Bryceson, AD | 1 |
| Korff, F; Wiskemann, A | 1 |
1 review(s) available for chloroquine and griseofulvin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for chloroquine and griseofulvin
| Article | Year |
|---|---|
[Comparative results of treating lichen ruber planus by various methods].
Topics: Adolescent; Adult; Aged; Aspirin; Bismuth; Child; Child, Preschool; Chloroquine; Chronic Disease; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Female; Griseofulvin; Humans; Isoniazid; Lichen Planus; Male; Middle Aged; Prednisolone | 1977 |
16 other study(ies) available for chloroquine and griseofulvin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship | 2014 |
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2014 |
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities.
Topics: Anti-Infective Agents; Antimalarials; Folic Acid Antagonists; Molecular Docking Simulation; Oxadiazoles; Spectrum Analysis; Triazoles | 2017 |
Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Benzothiazoles; Cell Survival; Computer Simulation; Dose-Response Relationship, Drug; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Quantum Theory; Schizosaccharomyces; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2017 |
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Study of the effects of certain drugs on experimental porphyria in rats.
Topics: Animals; Chloroquine; Dicarbethoxydihydrocollidine; Ethanol; Griseofulvin; Liver; Phenobarbital; Porphyrias; Porphyrins; Rats; Time Factors | 1977 |
Influence of higher rates of agitation on release patterns of immediate-release drug products.
Topics: Chloroquine; Griseofulvin; Hydroxychloroquine; Isocarboxazid; Primaquine; Quality Control; Solubility; Sulfadiazine; Tablets | 1992 |
Current concepts of cutaneous porphyria and its treatment with particular reference to the use of sodium calciumedetate.
Topics: Australia; Barbiturates; Chloroquine; Cholestyramine Resin; Diet Therapy; Edetic Acid; Estrogens; Griseofulvin; Humans; Porphyrias; Sulfonamides; Sunburn | 1970 |
[Porphyrin synthesis in liver cell culture under the influence of drugs and steroids].
Topics: 17-Ketosteroids; Androstanes; Animals; Anti-Bacterial Agents; Barbiturates; Chick Embryo; Chloramphenicol; Chloroquine; Culture Techniques; Dactinomycin; Glutethimide; Griseofulvin; Hypnotics and Sedatives; Liver; Meprobamate; Mitomycins; Oxyphenbutazone; Porphyrins; Pregnanediol; Pregnanes; Pregnanetriol; Puromycin; Pyridines; Spectrophotometry; Stimulation, Chemical; Sulfamoxole | 1969 |
Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment.
Topics: Adolescent; Amidines; Amphotericin B; Antimony; Antiprotozoal Agents; Child; Chloroquine; Female; Gluconates; Griseofulvin; Humans; Immunity; Leishmaniasis; Primaquine; Proguanil; Sulfonic Acids | 1970 |
[The effect of procaine, griseofulvin and chloroquine on skin perfusion in progressive scleroderma].
Topics: Chloroquine; Griseofulvin; Humans; Procaine; Regional Blood Flow; Scleroderma, Systemic; Skin | 1967 |